Single Automated Analyzer to Bring Full Suite of Diagnostics to Wherever Patients Are
|
By HospiMedica International staff writers Posted on 04 May 2023 |
|
Timely and accurate diagnostics can enhance patient care by making it more informed, personalized, and proactive. Now, a novel platform that delivers swift results using minimal blood volumes incorporates technology that facilitates automation and adaptable form factors outside centralized labs, bridging the gap between diagnostics and treatment.
Vital Biosciences Inc. (Mississauga, ON, Canada) is developing a single automated device designed to provide a comprehensive range of diagnostics directly to patients. The company's technology strives to make healthcare significantly more personalized, proactive, and accessible. With only 600 uL of blood, the platform can measure 50+ of the most commonly requested biomarkers in primary care within 20 minutes, without compromising analytical performance. The instrument employs an automated microfluidic workflow to simultaneously run three subsystems: hematology, clinical chemistry, and immunoassays. The platform quantifies the complete panel of biomarkers using on-board optical readers and automated sample preparation and measurement procedures that require minimal user input. This makes the platform suitable for use in CLIA-waived settings.
Vital's initial menu caters to a broad range of potential use cases for the general population, including inflammation, cardiac markers, diabetes, liver disorders, lipid disorders, post-acute event monitoring, clinical trial monitoring, chronic disease management, and proactive lifestyle management. The company aims to create a comprehensive menu that covers 100% of the tests needed for at least 90% of patients, thereby eliminating the need to send tests to a centralized lab. Patients would no longer need to travel to a draw site or ship their samples to a centralized laboratory, nor wait for days to discuss their results with their healthcare provider. Patients who are likely to require bloodwork can provide their sample at check-in and receive results during their initial appointment. Bridging this care gap will make diagnostics more accessible and accelerate clinical decision-making.
Related Links:
Vital Biosciences Inc.
Latest Point of Care News
- Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes
- Microneedle Patch Enables At-Home Monitoring of Acute Kidney Injury
- Ultrathin Metasurface Could Bring Quantitative Phase Imaging to Portable Devices
- Rapid Onsite Testing Reduces Emergency Department Transfers in Long-Term Care
- New Brain Ultrasound Platform Enables Bedside Postoperative Imaging
- Handheld Ultrasound Expands Point-of-Care Imaging Access in Brazil
- AI Dermatology Platform Targets Early Detection of Non-Melanoma Skin Cancer
- Handheld AI Device for Point-of-Care Skin Lesion Assessment Receives CE Mark
- Portable Immunoassay System Advances Toward Point-of-Care Biomarker Testing
- Portable MRI System Accelerates Emergency Brain Imaging and Triage
- Point-of-Care Viscoelastic Testing System Supports Obstetric Bleeding Management
- Portable MRI System Gains CE Mark for Point-of-Care Brain Imaging
Channels
Artificial Intelligence
view channel
AI Model Predicts Prolonged Sitting in Chronic Pelvic Pain
Chronic pelvic pain affects an estimated one in seven women and can occur with conditions such as endometriosis, adenomyosis, or uterine fibroids. Pain, fatigue, and other symptoms may contribute to prolonged... Read more
Autonomous AI Helps Streamline Urgent Skin Cancer Referrals
Urgent suspected skin cancer referrals place substantial pressure on dermatology services. In England, referrals have almost tripled since 2009, yet only about 6% lead to an urgent skin cancer diagnosis.... Read more
Critical Care
view channel
AI Tool Combining ECG and Blood Tests Reduces Unnecessary Heart Transplant Biopsies
Cardiac transplant rejection occurs when a recipient’s immune system attacks a donated heart. Diagnosis currently relies on biopsy, an invasive procedure in which heart muscle tissue is removed and examined... Read more
Deep Brain Stimulation Window May Matter for Parkinson’s Patients With GBA1 Variants
Patients with GBA1 gene variants may develop significant physical symptoms earlier in life while also facing greater vulnerability to cognitive problems. This combination can complicate decisions about... Read more
FDA-Approved App Enables Pulmonary Pressure Monitoring and Medication Guidance in Heart Failure
Heart failure is a chronic, progressive condition and a leading cause of hospitalization, with clinical status often deteriorating before symptoms appear. Rising pulmonary artery pressure can precede decompensation... Read more
Surgical Techniques
view channel
Matrix-Based Skin Substitute Improves Closure of Diabetic Foot Ulcers
Diabetic foot ulcers are hard-to-heal wounds that can persist because of chronic inflammation and moisture imbalance. When standard care alone does not achieve timely closure, clinicians may use adjunctive... Read more
New FDA-Approved Pediatric Pulmonary Valve Can Expand as Children Grow
Congenital pulmonary valve disease affects the valve that directs blood from the heart to the lungs. Even after repair, some children develop valve leakage that can strain and enlarge the right side of the heart.... Read more
Patient Care
view channel
At-Home Neuromodulation Shows Promise in Selected Patients With Hypertension
High blood pressure is a major risk factor for cardiovascular disease, including heart attack and stroke. Many patients receiving treatment for hypertension still remain above recommended blood pressure... Read more
EHR Model Flags High-Risk Periods in Patients with Metastatic Breast Cancer
Determining when patients with metastatic breast cancer are nearing the end of life remains difficult, often leading to intensive interventions with limited benefit. Prognostic uncertainty can delay goals-of-care... Read more
Medical Imaging
view channel
AI Software Detects Osteoporosis from Routine CT Scans
Osteoporosis can progress for years without pain, leaving bone loss undetected until a fracture or back pain prompts testing. By that point, bone loss may already be advanced. Bone density testing is not... Read more
AI Model Uses Pretreatment CT Scans to Predict Immunotherapy-Related Pneumonitis Risk
Pneumonitis is a potentially life-threatening form of lung inflammation that affects about 10% of patients with lung cancer receiving immunotherapy. Because it can be difficult to predict before symptoms... Read more
Health IT
view channel
Adaptive Radiation QA Software Gains Validation for NeoArc Treatments
Adaptive radiation therapy allows clinicians to adjust treatment plans to daily anatomical changes such as tumor shrinkage, weight loss, or organ movement, improving precision while limiting exposure to... Read more
Healthcare Database Helps Close Long COVID Surveillance Gap
Long COVID is a chronic condition that occurs after SARS-CoV-2 infection and lasts at least three months. It can follow severe illness, but it can also affect anyone who has been infected.... Read more
Business
view channel
World Health Expo to Showcase Trillion-Dollar Growth Across Pharma, Biotech, Longevity and Wellness at 2027 Edition
World Health Expo (WHX) expands with the new Pharma, Biotech, Longevity and Wellness industry sectors More than 235,000 professional visits, over 4,200 exhibitors and representatives from over... Read more
Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery
As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Robotic Single-Port System Gains CE Mark for Transvaginal Gynecologic Procedures
Intuitive (Sunnyvale, CA, USA) announced that it has received CE mark approval for use of the da Vinci SP Single Port surgical system in transvaginal gynecologic procedures, marking the first such indication... Read more